@Article{cju.2026.078958,
AUTHOR = {Mallory Pine, Marium Ansari, Alise Hale, Ramzy Burns, Helen L. Bernie},
TITLE = {Overlooked and undertreated: the role of female sexual dysfunction in male sexual health outcomes},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {},
YEAR = {},
NUMBER = {},
PAGES = {{pages}},
URL = {http://www.techscience.com/CJU/online/detail/27661},
ISSN = {1488-5581},
ABSTRACT = {<b>Introduction:</b> Male sexual dysfunction (MSD) is a prevalent condition traditionally evaluated and treated through a male-centric lens, despite growing recognition that sexual health is inherently relational. Emerging evidence demonstrates that female sexual dysfunction (FSD) plays a critical role in shaping male sexual outcomes, treatment satisfaction, and overall relationship well-being. FSD is common, multifactorial, and influenced by biological, psychological, and relational factors, with prevalence estimates varying depending on the presence of associated distress. Similarly, MSD encompasses a broad spectrum beyond erectile dysfunction, including ejaculatory disorders, hypogonadism, and penile deformity, many of which remain underrecognized. Across multiple studies, FSD is consistently associated with poorer male sexual outcomes, reduced satisfaction, and increased distress among male partners, while improvements in male sexual function may positively influence female outcomes, highlighting a bidirectional relationship. Despite this, partner sexual health is inconsistently assessed in clinical practice and underrepresented in medical training. Furthermore, few studies have evaluated female sexual outcomes following advanced MSD treatments such as penile prosthesis implantation using validated instruments. This review synthesizes current evidence on the prevalence and interrelationship of FSD and MSD, examines gaps in clinical training and research, and emphasizes the need for a couple-centered approach to sexual health to optimize outcomes for both partners.},
DOI = {10.32604/cju.2026.078958}
}